These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1006 related articles for article (PubMed ID: 36330513)

  • 41. Cuproptosis-related lncRNA signature as a prognostic tool and therapeutic target in diffuse large B cell lymphoma.
    Bai X; Lu F; Li S; Zhao Z; Wang N; Zhao Y; Ma G; Zhang F; Su X; Wang D; Ye J; Li P; Ji C
    Sci Rep; 2024 Jun; 14(1):12926. PubMed ID: 38839842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Novel Immune-Related lncRNA-Based Model for Survival Prediction in Clear Cell Renal Cell Carcinoma.
    Zhang Z; Tang Y; Liu Y; Zhuang H; Lin E; Xie L; Feng X; Tian K; Zeng J; Liu J; Yu Y
    J Immunol Res; 2021; 2021():9921466. PubMed ID: 34368371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcriptomic correlates of cell cycle checkpoints with distinct prognosis, molecular characteristics, immunological regulation, and therapeutic response in colorectal adenocarcinoma.
    Wang H; Wang W; Wang Z; Li X
    Front Immunol; 2023; 14():1291859. PubMed ID: 38143740
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A robust signature of immune-related long non-coding RNA to predict the prognosis of bladder cancer.
    Lai C; Wu Z; Li Z; Yu H; Li K; Tang Z; Liu C; Xu K
    Cancer Med; 2021 Sep; 10(18):6534-6545. PubMed ID: 34374227
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immune Infiltration Subtypes Characterization and Identification of Prognosis-Related lncRNAs in Adenocarcinoma of the Esophagogastric Junction.
    Hu X; Wu L; Liu B; Chen K
    Front Immunol; 2021; 12():651056. PubMed ID: 34122409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
    Fan Q; Liu B
    Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.
    Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J
    Front Immunol; 2022; 13():881359. PubMed ID: 35911752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Construction and Validation of a Reliable Disulfidptosis-Related LncRNAs Signature of the Subtype, Prognostic, and Immune Landscape in Colon Cancer.
    Dong X; Liao P; Liu X; Yang Z; Wang Y; Zhong W; Wang B
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
    Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
    Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma.
    Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J
    Front Genet; 2022; 13():838624. PubMed ID: 35928454
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma.
    Zhou M; Zhao H; Wang Z; Cheng L; Yang L; Shi H; Yang H; Sun J
    J Exp Clin Cancer Res; 2015 Sep; 34(1):102. PubMed ID: 26362431
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Zhu W; Ye Z; Chen L; Liang H; Cai Q
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer.
    Wang J; Shen C; Dong D; Zhong X; Wang Y; Yang X
    Int Immunopharmacol; 2021 Jan; 90():107146. PubMed ID: 33189610
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Construction of an N6-methyladenosine lncRNA- and immune cell infiltration-related prognostic model in colorectal cancer.
    Yu ZL; Zhu ZM
    Protoplasma; 2022 Jul; 259(4):1029-1045. PubMed ID: 34734333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
    Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
    Front Immunol; 2022; 13():854785. PubMed ID: 35392086
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Novel Pyroptosis-Associated Long Noncoding RNA Signature to Predict the Prognosis of Patients with Colorectal Cancer.
    Chen S; Zhu J; Zhi X
    Int J Gen Med; 2021; 14():6111-6123. PubMed ID: 34611426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of a Prognostic Colorectal Cancer Model Including LncRNA FOXP4-AS1 and LncRNA BBOX1-AS1 Based on Bioinformatics Analysis.
    Shi ZL; Zhou GQ; Guo J; Yang XL; Yu C; Shen CL; Zhu XG
    Cancer Biother Radiopharm; 2022 Dec; 37(10):893-906. PubMed ID: 33481661
    [No Abstract]   [Full Text] [Related]  

  • 58. Construction of an immune gene expression meta signature to assess the prognostic risk of colorectal cancer patients.
    Orozco-Castaño C; Mejia-Garcia A; Zambrano Y; Combita AL; Parra-Medina R; Bonilla DA; González A; Odriozola A
    Adv Genet; 2024; 112():207-254. PubMed ID: 39396837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and functional analysis of lncRNAs and mRNAs between tumorigenesis and metastasis in CRC.
    Liu H; Tian Y; Li J; Zhang G; Liu Q; Yang M; Yue L; Cao Q; Zhang G; Cheng Y; Kong N; Fang L; Li S; Sun Q
    Aging (Albany NY); 2021 Dec; 13(24):25859-25885. PubMed ID: 34954693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
    Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
    Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.